These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25416535)

  • 61. Optimised dosing of vancomycin in critically ill Indigenous Australian patients with severe sepsis.
    Tsai D; Stewart PC; Hewagama S; Krishnaswamy S; Wallis SC; Lipman J; Roberts JA
    Anaesth Intensive Care; 2018 Jul; 46(4):374-380. PubMed ID: 29966110
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation.
    Surovoy YA; Burkin MA; Galvidis IA; Bochkov PO; Oganesyan AV; Tsarenko SV
    J Antimicrob Chemother; 2022 Apr; 77(5):1379-1384. PubMed ID: 35134959
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Therapeutic Drug Monitoring of Vancomycin in Pediatric Patients With Extracorporeal Membrane Oxygenation Support.
    Zylbersztajn BL; Izquierdo G; Santana RC; Fajardo C; Torres JP; Cordero J; Valverde C
    J Pediatr Pharmacol Ther; 2018; 23(4):305-310. PubMed ID: 30181721
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
    De Waele JJ; Danneels I; Depuydt P; Decruyenaere J; Bourgeois M; Hoste E
    Int J Antimicrob Agents; 2013 May; 41(5):434-8. PubMed ID: 23410793
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Population Pharmacokinetic Analysis to Study the Effect of Extracorporeal Membrane Oxygenation on Cefepime Disposition in Children.
    Zuppa AF; Zane NR; Moorthy G; Dalton HJ; Abraham A; Reeder RW; Carcillo JA; Yates AR; Meert KL; Berg RA; Sapru A; Mourani P; Notterman DA; Dean JM; Gastonguay MR;
    Pediatr Crit Care Med; 2019 Jan; 20(1):62-70. PubMed ID: 30431557
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME; Lipman J; Tett SE
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of extracorporeal membrane oxygenation on tobramycin pharmacokinetics in sheep.
    Möller JC; Gilman JT; Kearns GL; Sussmane JB; Raszynski A; Wolfsdorf J; Reed MD
    Crit Care Med; 1992 Oct; 20(10):1454-8. PubMed ID: 1395668
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
    Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of flexible bronchoscopy in pediatric patients receiving extracorporeal membrane oxygenation (ECMO) support.
    Kamat PP; Popler J; Davis J; Leong T; Piland SC; Simon D; Harsch A; Teague WG; Fortenberry JD
    Pediatr Pulmonol; 2011 Nov; 46(11):1108-13. PubMed ID: 21815274
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.
    Ahsman MJ; Wildschut ED; Tibboel D; Mathot RA
    Antimicrob Agents Chemother; 2010 May; 54(5):1734-41. PubMed ID: 20176908
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dose Optimization of Cefpirome Based on Population Pharmacokinetics and Target Attainment during Extracorporeal Membrane Oxygenation.
    Kang S; Jang JY; Hahn J; Kim D; Lee JY; Min KL; Yang S; Wi J; Chang MJ
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122899
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.
    Lin H; Yeh DD; Levine AR
    Crit Care; 2016 Jul; 20(1):205. PubMed ID: 27363312
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
    Beumier M; Roberts JA; Kabtouri H; Hites M; Cotton F; Wolff F; Lipman J; Jacobs F; Vincent JL; Taccone FS
    J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.
    Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; Devigili A; Cianferoni S; de Backer D; Jacobs F; Cotton F; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2012 Apr; 39(4):332-7. PubMed ID: 22333933
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software.
    Roberts JA; Bellomo R; Cotta MO; Koch BCP; Lyster H; Ostermann M; Roger C; Shekar K; Watt K; Abdul-Aziz MH
    Intensive Care Med; 2022 Oct; 48(10):1338-1351. PubMed ID: 35997793
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation.
    Pokorná P; Šíma M; Vobruba V; Tibboel D; Slanař O
    Perfusion; 2018 May; 33(1_suppl):80-86. PubMed ID: 29788839
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of outcome scoring systems for patients on extracorporeal membrane oxygenation.
    Lin CY; Tsai FC; Tian YC; Jenq CC; Chen YC; Fang JT; Yang CW
    Ann Thorac Surg; 2007 Oct; 84(4):1256-62. PubMed ID: 17888979
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation.
    Shekar K; Abdul-Aziz MH; Cheng V; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Roberts JA
    Am J Respir Crit Care Med; 2023 Mar; 207(6):704-720. PubMed ID: 36215036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.